Brain Tumor Behind Incredible 73% Win Rate & Beat Market by 254%. | 6 May

Unsubscribe Web Version

Below is a message from our partners that we thought you'd enjoy: A brain tumor turned a struggling trader… Into one of the most successful traders you’ve probably never heard of: Bobby Iaccino. Over the past few decades, Bobby has: Day traded in the Chicago trading pits with some of the biggest banks and brokerage firms in the world. Worked at Smith Barney and Germany’s Commerzbank. Ran his own commodity pool at a Chicago based trading firm. Principal and member of the investment committee for a very successful fund of hedge funds. Been interviewed over 2,000 times about the markets on CNBC, Bloomberg, Fox Business, Yahoo! Finance, TD Ameritrade, and so on. But most importantly… The brain tumor has given Bobby an unfair advantage in the markets for over 28 years... And in the past year alone, Bobby's system has racked up win after win… Generating a 73.3% win rate and beating the S&P 500 by 254%... Now, after a full year of trading, rigorous testing and verifiable proof of just how profitable his system is… Bobby Iaccino is ready to pull open the curtains and show you everything. Get the details on Bobby’s system here, before he goes public. His approach could transform your trading and lead to life changing results. It completely removes fear, stress and uncertainty from trading. Discover why and how this system will be even more important in 2021. P.S. Bobby’s unique approach consistently beats the market… Take emotions out of trading… Keep losses to a minimum, profits to a maximum… And can help anyone survive and thrive the ups and downs of the news cycles and events Discover the powerful system that’s perfect for the markets this year... Copyright 2021. Crypto Ramp. All Rights Reserved. Any replication or reproduction of this content is strictly prohibited.

This email was sent by: Crypto Ramp 443 Western Ave Ste 122, South Portland, ME, 04106 USA Privacy Policy Update Profile      Manage Subscriptions       Unsubscribe